LL-37 and MK-677 Interaction

Synergistic
Mechanism-based 47% confidence

LL-37 and MK-677 have a synergistic interaction with 47% confidence. LL-37 and MK-677 work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. These compounds primarily affect different organ systems.

Compound Profiles

LL-37

Human Cathelicidin | Antimicrobial Peptide

Provides direct antimicrobial activity through membrane disruption, promotes wound healing by enhancing keratinocyte migration and angiogenesis, and modulates immune responses without systemic exposure when used topically..

Half-life: Short (rapid proteolytic degradation) Typical dose: 0.5-1.6 mg/mL topical gel or 100-150 mcg injectable immune, healing
View full profile

MK-677

Ghrelin Receptor Agonist | Oral Growth Hormone Secretagogue

Selectively binds GHS-R1a receptors in hypothalamus and pituitary, triggering pulsatile growth hormone release while maintaining natural circadian patterns..

Half-life: ~24 hours Typical dose: Start 12.5mg daily, increase to 25mg based on tolerance growth hormone, weight loss, sleep
ghrelin receptor blood pressure raisingcarcinogenic riskhepatotoxicinsulin disrupting
View full profile

Combined Organ Load

Blood Vessels
low
Brain
low
GI Tract
low
Pituitary
low

Frequently Asked Questions

Can I take LL-37 with MK-677?

Yes, LL-37 and MK-677 can generally be taken together. LL-37 and MK-677 work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols.

Is LL-37 and MK-677 safe together?

Based on pharmacological analysis, this combination is considered synergistic. No critical safety flags identified for this pair.

What are the interactions between LL-37 and MK-677?

LL-37 and MK-677 work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time LL-37 and MK-677?

LL-37 has a half-life of Short (rapid proteolytic degradation) and MK-677 has a half-life of ~24 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: LL-37 vs MK-677

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.